APOB and metabolic syndrome: According to that, the retention of LDL and other cholesterol-rich apolipoprotein (Apo) B containing lipoproteins in the arterial wall is the initial cause of atherogenesis [21] and lowering LDL values reduces the risk of future cardiovascular events, with no minimum threshold [7], it becomes imperative to enhance the screening and treatment of dyslipidemia in our population.